Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
more importantly someone bought @ .0007. Wonder if we will see another mini run again, or if this is the start of something bigger?
Got some buying action today. Why?
I don't think anyone would be against you running it up to .02 again.
Try this link. The page has been disabled but you can get there through Google cache.
http://webcache.googleusercontent.com/search?q=cache:lTXwNCIeW_wJ:www.graystone1.com/current-offerings+&cd=1&hl=en&ct=clnk&gl=us
Looks good to me. Asher has converted and registered as a beneficial owner. They will have to report when they sell.
http://sec.gov/Archives/edgar/data/1510524/000118518512001936/graystone8k082712.htm
Item 3.02 Unregistered Sales of Equity Securities
(a) On August 27 2012, the Company issued 4,105,263 shares of Class A Common stock at an applicable conversion price of $0.00095. Asher Enterprises converted $2,200 of its note convertible in the amount of $42,500. The agreement with Asher allows them to convert their debt after six (6) months at a conversion price equal to the lowest closing bid price twenty trading days prior to the conversion date. The conversion on August 27, 2012 brings the entire amount converted on the November 29, 2011 note to $44,200 which includes the principal balance of $42,500 and interest of $1,700.
http://sec.gov/Archives/edgar/data/1506797/000114420412048115/v322478_sc13g.htm
Ownership
(a) Amount beneficially owned 17,906,207
(b) Percent of class: 9.99%
(c) Number of shares as to which the person has:
If by "In Business" you mean selling worthless shares to people then yes they are still in business. If you meant the Oil business, then not so much. Unless you count the 4 barrels a month that their CEO James Renfro brought with him.
so what do you think? A dump then pump going on here?
Hey! What exactly were you taking a picture of in the second picture? looks like that container got in the way of a really nice view. LOL
Go Pack GO!
I agree. It is one thing to question the long term value of a company, but when people claim insiders are selling when you can look and see that it isn't true I need to say something. You never know how many people randomly come on to the ELTP board look at 5-10 posts and see someone saying insiders are selling and move on just because their first impression is that it isn't a good buy. It is a shame, but that is human nature.
Well, I bet that if you had knocked on Treppel's door in 2009 with $3 million in your hand and 8 drugs that Elite could use to generate revenues for years to come then you would have received a pretty sweet deal too. I guarantee that you couldn't get the same deal today. The cost of doing business has gone up for those that want a piece of Elite.
Umm, you have had more than three years to read the agreement between Epic and Elite. Nothing outrageous about it. The few shares that Epic has sold is a drop in the bucket of what they own.
There must be some sort of plan for them to off load all those shares. Otherwise they wouldn't have accepted them as payment. Just wish I knew when they planned to start the pump. getting in a week or two before could make a lot of money.
With the massive amount of shares given out do you think there will be an orchestrated pump coming in the next few months so the holders of these shares can cash out? Would now be a good time to buy in anticipation of whatever marketing scheme they come up with? Or do you think it will continue to go lower as time passes making the current pps not a good value?
Wow, how is this not trading at .0001?? has anyone bothered to read the 10q that was recently filed?
check out this -
Stock Issued for Services
During the year ended February 29, 2012, the Company issued 483,075,003 shares of its restricted common stock to various individuals and entities for services and company support.
During the quarter ended, May 31, 2012, the Company issued 1,250,000 003 shares of its restricted common stock to various individuals and entities for services and company support.
I didn't particularly like the Socius deal, but I also believed that Treppel will do the right thing for ELTP. I believe that even more after he put up his own money.
There could be a million reasons why Epic doesn't fund the trials. Nobody on this board can give you the actual reason why. It will only be an opinion. It also isn't an answer that you will get in a conference call. It just doesn't work that way. They are there to talk about what they've done and what they are working toward. they won't give intimate details about future transactions. It just doesn't happen.
Since you are looking for a scenario I'll give you my opinion. Epic isn't funding the trials because they have already put in quite a bit of money, and control a significant portion of ELTP. Why put more money in when someone else can put up the money and then Epic will profit off of someone else's investment? Since they have significant control of ELTP they can make sure that what ever funding deal is done won't hurt them. Therefore, Epic doesn't need to invest more money to significantly profit from ELTP.
Wow, that is great information. Wouldn't it be fantastic if you could provide proof of this?
Highest close in last 42 months, .18
Can anyone please confirm that you can buy BRZL shares with an ETRADE account? I want to buy more, but cannot with ameritrade. Thank you
I've read the 10k many times, but I didn't need to read it to know the statement you posted. All investors should look at the diluted share count, and then research why that number exists. This goes back to a 2009 agreement with Epic. It is nothing new.
http://sec.gov/Archives/edgar/data/1053369/000093041309001530/c56987_8k.htm
Are you suggesting that the single largest insider would want to reduce the number of shares that they own by doing a reverse split? Why would they do that?
I had noticed that R&D costs were particularly high for Q4 this year and was wondering if there was a trend that could help us better predict what future 10ks might have in store. I'm not sure we can say the last two years equals a trend, but I find the data interesting.
The first chart shows R&D and Admin expenses for Q4 as a percentage of themselves for the full year. The second shows R&D and Admin expenses as a percentage of Total Expenses for the year.
Well, count me in on those that don't care. I'm not a pharma person I'm an IT guy, more specifically a Business Intelligence Specialist. I care about the numbers behind the company, which I believe are positive for the future. All the arguments about pharma technology really don't mean anything to me.
I don't understand the point of this discussion. Why do we care if ELTP buys the active ingredient or makes it themselves?
I double checked my numbers for GP in fiscal year 2012 and they look correct.
Q1 564,608
Q2 197,801
Q3 353,348
Q4 294,687
which one?
I just realized you posted this. I originally created it and hadn't read the board today and thought it was about time I updated my chart. So I posted the new chart without knowing you had already done it.
I tried updating the IBOX, but it says my firewall is blocking my PC from pasting in the chart. If one of the other mods could please update the IBOX that would be great. Thank you.
Trading ended at 1pm EST. due to the holiday.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77182681
FYI - if ELTP needs more cash they can get a $1 million loan from Epic
If the Registrant determines, in its reasonable judgment, that additional funding is required for the development of its pharmaceutical products, then, either (i) the Registrant will issue, and the Purchaser will purchase, such additional number of shares of Series E Preferred Stock or Common Stock from the Registrant, upon such terms and conditions as may be agreed upon by the Registrant and Epic at the time of such determination; or (ii) on or after September 15, 2011, Epic will provide a loan to the Registrant, in an aggregate principal amount not to exceed US$1,000,000, which such loan will (A) have an interest rate equal to the then prime
interest rate as published in the Wall Street Journal on the date of such loan, (B) mature on the 2nd anniversary of date of such loan, and (C) be on such other terms and conditions which are customary and reasonable to loans of a similar nature and which are mutually agreed upon between Epic and the Registrant.
http://sec.gov/Archives/edgar/data/1053369/000093041309001530/c56987_8k.htm
Well, this is directly related to the Epic Alliance.
http://sec.gov/Archives/edgar/data/1053369/000093041309001530/c56987_8k.htm
In addition, within ten business days following the last day of each calendar quarter, beginning with the first calendar quarter following the Initial Closing Date and continuing for each of the eleven calendar quarters thereafter, the Purchaser will pay to the Registrant a sum of US$62,500, for an aggregate purchase price over such period of US$750,000, in exchange for an additional 62.5 shares of Series E Preferred Stock per quarter and 750 shares of Series E Preferred Stock, in the aggregate, over such period, which such shares will be convertible into 1,250,000 shares of Common Stock per quarter and 15,000,000 shares of Common Stock, in the aggregate, over such period, subject to adjustment
7,684,427 shares.
From the 10k
As of June 22, 2012, there were, respectively, approximately 141, 0, 8 and 1 holders of record of our Common Stock, Series B Preferred Stock, Series C Preferred Stock and Series E Preferred Stock.
Series B Preferred shares Outstanding as of March 31, 2012 797
Conversion of Series B and Series C Convertible Preferred Stock to Common Stock
During the period beginning on April 1, 2012 and ending on the date of filing of this Annual Report on Form 10-K, a total of 797 shares of Series B Preferred Stock, representing all shares of Series B Preferred Stock then issued and outstanding, were converted into a total of 5,310,387 shares of Common Stock. In addition, a total of 1,216 shares of Series C Preferred Stock were converted into a total of 8,106,667 shares of Common Stock.